MSTO1 is a cytoplasmic pro-mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humans

Aniko Gal, Peter Balicza, David Weaver, Shamim Naghdi, Suresh K. Joseph, Péter Várnai, Tibor Gyuris, Attila Horváth, Laszlo Nagy, Erin L. Seifert, Maria Judit Molnar, György Hajnóczky

Research output: Contribution to journalArticle

Abstract

The protein MSTO1 has been localized to mitochondria and linked to mitochondrial morphology, but its specific role has remained unclear. We identified a c.22G > A (p.Val8Met) mutation of MSTO1 in patients with minor physical abnormalities, myopathy, ataxia, and neurodevelopmental impairments. Lactate stress test and myopathological results suggest mitochondrial dysfunction. In patient fibroblasts, MSTO1 mRNA and protein abundance are decreased, mitochondria display fragmentation, aggregation, and decreased network continuity and fusion activity. These characteristics can be reversed by genetic rescue. Short-term silencing of MSTO1 in HeLa cells reproduced the impairment of mitochondrial morphology and dynamics observed in the fibroblasts without damaging bioenergetics. At variance with a previous report, we find MSTO1 to be localized in the cytoplasmic area with limited colocalization with mitochondria. MSTO1 interacts with the fusion machinery as a soluble factor at the cytoplasm-mitochondrial outer membrane interface. After plasma membrane permeabilization, MSTO1 is released from the cells. Thus, an MSTO1 loss-of-function mutation is associated with a human disorder showing mitochondrial involvement. MSTO1 likely has a physiologically relevant role in mitochondrial morphogenesis by supporting mitochondrial fusion.

Original languageEnglish (US)
Pages (from-to)967-984
Number of pages18
JournalEMBO Molecular Medicine
Volume9
Issue number7
DOIs
StatePublished - Jul 1 2017
Externally publishedYes

Fingerprint

Mitochondrial Dynamics
Mitochondrial Proteins
Muscular Diseases
Ataxia
Mitochondria
Mutation
Fibroblasts
Mitochondrial Diseases
Mitochondrial Membranes
Exercise Test
Morphogenesis
HeLa Cells
Energy Metabolism
Lactic Acid
Cytoplasm
Proteins
Cell Membrane
Messenger RNA

Keywords

  • misato
  • mitochondria
  • mitochondrial disease
  • mitochondrial fusion
  • MSTO1

ASJC Scopus subject areas

  • Molecular Medicine

Cite this

Gal, A., Balicza, P., Weaver, D., Naghdi, S., Joseph, S. K., Várnai, P., ... Hajnóczky, G. (2017). MSTO1 is a cytoplasmic pro-mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humans. EMBO Molecular Medicine, 9(7), 967-984. https://doi.org/10.15252/emmm.201607058

MSTO1 is a cytoplasmic pro-mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humans. / Gal, Aniko; Balicza, Peter; Weaver, David; Naghdi, Shamim; Joseph, Suresh K.; Várnai, Péter; Gyuris, Tibor; Horváth, Attila; Nagy, Laszlo; Seifert, Erin L.; Molnar, Maria Judit; Hajnóczky, György.

In: EMBO Molecular Medicine, Vol. 9, No. 7, 01.07.2017, p. 967-984.

Research output: Contribution to journalArticle

Gal, A, Balicza, P, Weaver, D, Naghdi, S, Joseph, SK, Várnai, P, Gyuris, T, Horváth, A, Nagy, L, Seifert, EL, Molnar, MJ & Hajnóczky, G 2017, 'MSTO1 is a cytoplasmic pro-mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humans', EMBO Molecular Medicine, vol. 9, no. 7, pp. 967-984. https://doi.org/10.15252/emmm.201607058
Gal, Aniko ; Balicza, Peter ; Weaver, David ; Naghdi, Shamim ; Joseph, Suresh K. ; Várnai, Péter ; Gyuris, Tibor ; Horváth, Attila ; Nagy, Laszlo ; Seifert, Erin L. ; Molnar, Maria Judit ; Hajnóczky, György. / MSTO1 is a cytoplasmic pro-mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humans. In: EMBO Molecular Medicine. 2017 ; Vol. 9, No. 7. pp. 967-984.
@article{eb4ddd758f694636b16b7d35166cc9fa,
title = "MSTO1 is a cytoplasmic pro-mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humans",
abstract = "The protein MSTO1 has been localized to mitochondria and linked to mitochondrial morphology, but its specific role has remained unclear. We identified a c.22G > A (p.Val8Met) mutation of MSTO1 in patients with minor physical abnormalities, myopathy, ataxia, and neurodevelopmental impairments. Lactate stress test and myopathological results suggest mitochondrial dysfunction. In patient fibroblasts, MSTO1 mRNA and protein abundance are decreased, mitochondria display fragmentation, aggregation, and decreased network continuity and fusion activity. These characteristics can be reversed by genetic rescue. Short-term silencing of MSTO1 in HeLa cells reproduced the impairment of mitochondrial morphology and dynamics observed in the fibroblasts without damaging bioenergetics. At variance with a previous report, we find MSTO1 to be localized in the cytoplasmic area with limited colocalization with mitochondria. MSTO1 interacts with the fusion machinery as a soluble factor at the cytoplasm-mitochondrial outer membrane interface. After plasma membrane permeabilization, MSTO1 is released from the cells. Thus, an MSTO1 loss-of-function mutation is associated with a human disorder showing mitochondrial involvement. MSTO1 likely has a physiologically relevant role in mitochondrial morphogenesis by supporting mitochondrial fusion.",
keywords = "misato, mitochondria, mitochondrial disease, mitochondrial fusion, MSTO1",
author = "Aniko Gal and Peter Balicza and David Weaver and Shamim Naghdi and Joseph, {Suresh K.} and P{\'e}ter V{\'a}rnai and Tibor Gyuris and Attila Horv{\'a}th and Laszlo Nagy and Seifert, {Erin L.} and Molnar, {Maria Judit} and Gy{\"o}rgy Hajn{\'o}czky",
year = "2017",
month = "7",
day = "1",
doi = "10.15252/emmm.201607058",
language = "English (US)",
volume = "9",
pages = "967--984",
journal = "EMBO Molecular Medicine",
issn = "1757-4676",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - MSTO1 is a cytoplasmic pro-mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humans

AU - Gal, Aniko

AU - Balicza, Peter

AU - Weaver, David

AU - Naghdi, Shamim

AU - Joseph, Suresh K.

AU - Várnai, Péter

AU - Gyuris, Tibor

AU - Horváth, Attila

AU - Nagy, Laszlo

AU - Seifert, Erin L.

AU - Molnar, Maria Judit

AU - Hajnóczky, György

PY - 2017/7/1

Y1 - 2017/7/1

N2 - The protein MSTO1 has been localized to mitochondria and linked to mitochondrial morphology, but its specific role has remained unclear. We identified a c.22G > A (p.Val8Met) mutation of MSTO1 in patients with minor physical abnormalities, myopathy, ataxia, and neurodevelopmental impairments. Lactate stress test and myopathological results suggest mitochondrial dysfunction. In patient fibroblasts, MSTO1 mRNA and protein abundance are decreased, mitochondria display fragmentation, aggregation, and decreased network continuity and fusion activity. These characteristics can be reversed by genetic rescue. Short-term silencing of MSTO1 in HeLa cells reproduced the impairment of mitochondrial morphology and dynamics observed in the fibroblasts without damaging bioenergetics. At variance with a previous report, we find MSTO1 to be localized in the cytoplasmic area with limited colocalization with mitochondria. MSTO1 interacts with the fusion machinery as a soluble factor at the cytoplasm-mitochondrial outer membrane interface. After plasma membrane permeabilization, MSTO1 is released from the cells. Thus, an MSTO1 loss-of-function mutation is associated with a human disorder showing mitochondrial involvement. MSTO1 likely has a physiologically relevant role in mitochondrial morphogenesis by supporting mitochondrial fusion.

AB - The protein MSTO1 has been localized to mitochondria and linked to mitochondrial morphology, but its specific role has remained unclear. We identified a c.22G > A (p.Val8Met) mutation of MSTO1 in patients with minor physical abnormalities, myopathy, ataxia, and neurodevelopmental impairments. Lactate stress test and myopathological results suggest mitochondrial dysfunction. In patient fibroblasts, MSTO1 mRNA and protein abundance are decreased, mitochondria display fragmentation, aggregation, and decreased network continuity and fusion activity. These characteristics can be reversed by genetic rescue. Short-term silencing of MSTO1 in HeLa cells reproduced the impairment of mitochondrial morphology and dynamics observed in the fibroblasts without damaging bioenergetics. At variance with a previous report, we find MSTO1 to be localized in the cytoplasmic area with limited colocalization with mitochondria. MSTO1 interacts with the fusion machinery as a soluble factor at the cytoplasm-mitochondrial outer membrane interface. After plasma membrane permeabilization, MSTO1 is released from the cells. Thus, an MSTO1 loss-of-function mutation is associated with a human disorder showing mitochondrial involvement. MSTO1 likely has a physiologically relevant role in mitochondrial morphogenesis by supporting mitochondrial fusion.

KW - misato

KW - mitochondria

KW - mitochondrial disease

KW - mitochondrial fusion

KW - MSTO1

UR - http://www.scopus.com/inward/record.url?scp=85019677384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019677384&partnerID=8YFLogxK

U2 - 10.15252/emmm.201607058

DO - 10.15252/emmm.201607058

M3 - Article

C2 - 28554942

AN - SCOPUS:85019677384

VL - 9

SP - 967

EP - 984

JO - EMBO Molecular Medicine

JF - EMBO Molecular Medicine

SN - 1757-4676

IS - 7

ER -